As of January 22, 2025, Otsuka Holdings (4578.T) has a market cap of $27.63 billion USD. According to our data, Otsuka Holdings is ranked No.711 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $27.63 B |
-6.95%
|
Dec 30, 2024 | $29.70 B |
65.21%
|
Dec 29, 2023 | $17.97 B |
25.40%
|
Dec 30, 2022 | $14.33 B |
5.52%
|
Dec 30, 2021 | $13.58 B |
-3.51%
|
Dec 30, 2020 | $14.08 B |
-7.56%
|
Dec 30, 2019 | $15.23 B |
11.34%
|
Dec 31, 2018 | $13.68 B |
-7.34%
|
Dec 29, 2017 | $14.76 B |
-0.85%
|
Dec 30, 2016 | $14.89 B |
20.42%
|
Dec 30, 2015 | $12.36 B |
22.27%
|
Dec 30, 2014 | $10.11 B |
22.79%
|
Dec 30, 2013 | $8.23 B |
27.37%
|
Dec 28, 2012 | $6.47 B |
14.96%
|
Dec 30, 2011 | $5.62 B |
10.80%
|
Dec 30, 2010 | $5.08 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Eli Lilly
LLY
|
$676.92 B |
0.020 M
|
USA
|
Novo Nordisk A/S
NOVO-B.CO
|
$365.09 B |
95.523 B
|
Denmark
|
Johnson & Johnson
JNJ
|
$347.78 B |
-0.005 M
|
USA
|
Novo Nordisk
NVO
|
$335.53 B |
64.154 B
|
Denmark
|
AbbVie
ABBV
|
$300.53 B |
0.002 M
|
USA
|
Roche
ROG.SW
|
$243.91 B |
38.073 B
|
Switzerland
|
Merck
MRK
|
$242.59 B |
0.007 M
|
USA
|
Thermo Fisher Scientific
TMO
|
$220.26 B |
-0.000 M
|
USA
|
AstraZeneca
AZN
|
$211.43 B |
0.005 M
|
UK
|
Novartis
NVS
|
$197.43 B |
0.007 M
|
Switzerland
|
Pfizer
PFE
|
$148.34 B |
-0.006 M
|
USA
|
Amgen
AMGN
|
$147.53 B |
0.002 M
|
USA
|
Sanofi
SNY
|
$128.55 B |
0.003 M
|
France
|
Gilead Sciences
GILD
|
$116.07 B |
0.004 M
|
USA
|
Bristol-Myers Squibb
BMY
|
$115.86 B |
0.003 M
|
USA
|
Vertex Pharmaceuticals
VRTX
|
$110.70 B |
-0.001 M
|
USA
|
CSL
CSL.AX
|
$82.06 B |
-0.963 B
|
Australia
|
Regeneron Pharmaceuticals
REGN
|
$76.77 B |
2.434 B
|
USA
|
Zoetis
ZTS
|
$75.24 B |
-0.341 B
|
USA
|
Chugai Pharmaceutical
4519.T
|
$69.96 B |
0.455 B
|
Japan
|
Market Cap | = | 4578.T Stock Price | * | 4578.T Shares Outstanding |
= | $51.44 | * | 0.54 B | |
= | $27.63 B |